This inventor holds 1 USPTO granted patent. Top assignee: Baxter International Inc.. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: Matthew Jenusaitia: Innovator in Blood Oxygenation Technology
Introduction
Matthew Jenusaitia is a notable inventor based in Irvine, CA (US). He has made significant contributions to the field of medical technology, particularly in the development of blood oxygenators. His innovative approach to controlling gas exchange in blood oxygenation systems has the potential to enhance patient care.
Latest Patents
Matthew holds a patent for his invention titled "O.sub.2 /CO.sub.2 control in blood oxygenators." This patent describes a blood oxygenator that independently regulates the exchange rates of oxygen and carbon dioxide between an oxygen-enriched gas and the blood. The design includes a gas inlet mechanism that diverts oxygen-enriched gas through two distinct pathways. The first pathway directs the gas to a diffusion plate or sparger, creating bubbles that facilitate gas exchange. The second pathway allows for a continuous stream of oxygen, affecting gas exchange across the blood-gas interface.
Career Highlights
Matthew is currently employed at Baxter International Inc., a leading company in the healthcare sector. His work focuses on advancing technologies that improve medical devices and patient outcomes. His innovative spirit and dedication to research have positioned him as a valuable asset in the field.
Collaborations
Matthew collaborates with Karl M. Sutherland, working together to push the boundaries of medical technology and improve the efficacy of blood oxygenation systems.
Conclusion
Matthew Jenusaitia's contributions to blood oxygenation technology exemplify the impact of innovation in healthcare. His patent and ongoing work at Baxter International Inc. highlight his commitment to enhancing medical devices for better patient care.